DBV Technologies (DBVT) Return on Capital Employed (QoQ) (2021 - 2026)

DBV Technologies (DBVT) Return on Capital Employed (QoQ) (2021 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 128.13 Bn 120.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 112.33 Bn 104.33 Bn 3.93 Bn
3 Argenx Se 53.24 Bn 48.05 Bn 1.41 Bn
4 Revolution Medicines 43.64 Bn 43.64 Bn -
5 BeOne Medicines 39.27 Bn 34.17 Bn 1.53 Bn
6 MindWalk Holdings 35.32 Bn 35.31 Bn 1.82 Bn
7 Royalty Pharma 33.72 Bn 35.84 Bn -
8 Alnylam Pharmaceuticals 30.58 Bn 27.27 Bn 992.69 Mn
9 Insmed 27.01 Bn 25.85 Bn 358.27 Mn
10 DBV Technologies 6.08 Bn 5.90 Bn -

Historic Data

Download Data
DateValue
Jun 30, 2026 -844.00
Mar 31, 2026 4,395.00
Dec 31, 2025 3,356.00
Sep 30, 2025 9,381.00
Jun 30, 2025 39,045.00
Mar 31, 2025 -40,490.00
Dec 31, 2024 -9,786.00
Sep 30, 2024 -5,374.00
Jun 30, 2024 -2,943.00
Mar 31, 2024 -948.00
Dec 31, 2023 826.00
Sep 30, 2023 -623.00
Jun 30, 2023 -449.00
Mar 31, 2023 -445.00
Dec 31, 2022 -1,410.00
Sep 30, 2022 1,564.00
Jun 30, 2022 3,489.00
Mar 31, 2022 -342.00
Dec 31, 2021 508.00
Sep 30, 2021 -661.00